Arvinas, Inc. (NASDAQ:ARVN) unveiled first-in-human data on Friday for its experimental Parkinson’s disease treatment, ARV-102. Results from the randomized, double-blind, placebo-controlled single ...

A country like Israel — a hi-tech hub — should have the basics in place for diseases like PSP. In a nation of 10 million, ...

While LRRK2 is primarily known for its role in Parkinson’s, Arvinas noted that emerging evidence suggests it also plays a role in tauopathies, including progressive supranuclear palsy (PSP).

Disease severity was measured using PSP Rating Scale for PSP participants (0 = no symptoms – 100) and Unified Parkinson's disease Rating Scale – motor subsection (UPDRS III) for PD ...

Clinical practices and diagnostic challenges increase misdiagnoses Commonly revised diagnoses included vascular parkinsonism, progressive supranuclear palsy, multiple system atrophy, and ...

PSP (a very little known neurological disease often seen as a variant of Parkinson’s) is possibly one of the “truly I don’t want that” diseases. It presents in its final stages as a toxic ...

Progressive supranuclear palsy (PSP) is characterized by progressive postural instability with falls, pseudobulbar palsy, axial parkinsonism, supranuclear vertical gaze palsy, executive ...

Clinical practices and diagnostic challenges increase misdiagnoses Commonly revised diagnoses include vascular parkinsonism, progressive supranuclear palsy, multiple system atrophy, and clinically ...

Elizabeth “Betsy” Brown of Saint Johns, Florida, age 74, died of pneumonia on March 20, 2025. For several years she suffered from Progressive Supranuclear Palsy (PSP) a movement disorder that ...